Kazutaka Aoki Selected Research

miglitol (Glyset)

2/2020	Comparison of Lipid-Lowering Effects of Anagliptin and Miglitol in Patients With Type 2 Diabetes: A Randomized Trial.
1/2016	Comparison of efficacy and safety of taking miglitol dissolved in water during a meal and taking a miglitol tablet just before a meal in patients with type 2 diabetes.
6/2012	Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
11/2011	Effects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance.
1/2010	Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.
1/2010	Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazutaka Aoki Research Topics

Disease

22	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2009
8	Body Weight (Weight, Body) 11/2021 - 04/2011
8	Insulin Resistance 11/2021 - 06/2003
5	Glucose Intolerance 01/2013 - 04/2004
5	Hyperglycemia 06/2012 - 06/2003
3	Fatty Liver 11/2021 - 05/2011
3	Inflammation (Inflammations) 11/2021 - 06/2003
3	Obesity 01/2018 - 06/2003
2	Hepatocellular Carcinoma (Hepatoma) 12/2005 - 04/2004
2	Hyperinsulinism (Hyperinsulinemia) 05/2004 - 06/2003
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Albuminuria 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Diabetes Mellitus 01/2018
1	Weight Loss (Weight Reduction) 07/2014
1	Overweight 10/2013
1	Vomiting 01/2013
1	Nausea 01/2013
1	Gastritis 01/2013
1	Heartburn (Pyrosis) 01/2013
1	Hypertension (High Blood Pressure) 08/2012
1	Essential Hypertension 08/2012
1	Dyslipidemias (Dyslipidemia) 10/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2010
1	Constipation 01/2010
1	Diarrhea 01/2010
1	Flatulence 01/2010
1	Hypoglycemia (Reactive Hypoglycemia) 04/2009
1	Alkalosis 07/2008

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 06/2003
8	Insulin (Novolin)FDA Link 01/2018 - 06/2003
7	LipidsIBA 09/2020 - 10/2010
6	miglitol (Glyset)FDA Link 02/2020 - 01/2010
4	Dehydroepiandrosterone (DHEA)IBA 01/2018 - 06/2003
3	CholesterolIBA 09/2020 - 05/2011
3	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2020 - 01/2010
3	LDL CholesterolIBA 02/2020 - 05/2011
3	IncretinsIBA 01/2013 - 11/2011
3	Glucagon (Glukagon)FDA Link 01/2013 - 11/2011
3	Sitagliptin Phosphate (Januvia)FDA Link 06/2012 - 01/2010
2	Glycoside Hydrolase InhibitorsIBA 02/2020 - 01/2010
2	Hypolipidemic Agents (Antihyperlipidemics)IBA 02/2020 - 01/2015
2	oxidized low density lipoproteinIBA 02/2020 - 01/2015
2	anagliptinIBA 02/2020 - 01/2015
2	AlbuminsIBA 03/2018 - 02/2015
2	1,5-anhydroglucitolIBA 03/2018 - 02/2015
2	Hormones (Hormone)IBA 01/2018 - 10/2016
2	SteroidsIBA 01/2018 - 12/2005
2	alogliptinIBA 08/2017 - 06/2013
2	glimepiride (Amarel)FDA LinkGeneric 08/2017 - 01/2016
2	repaglinide (Prandin)FDA Link 01/2016 - 10/2014
2	PotassiumIBA 07/2008 - 04/2004
2	EnzymesIBA 12/2005 - 06/2003
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021
1	CanagliflozinIBA 11/2021
1	C-Reactive ProteinIBA 11/2021
1	Liraglutide FDA Link 09/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 09/2020
1	dapagliflozinIBA 01/2019
1	Dehydroepiandrosterone SulfateIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 08/2017
1	Pioglitazone (Actos)FDA Link 08/2017
1	TabletsIBA 01/2016
1	Gliclazide (Diamicron)IBA 01/2016
1	Glyburide (Glibenclamide)FDA LinkGeneric 01/2016
1	Glycated Serum AlbuminIBA 02/2015
1	CreatinineIBA 02/2015
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 02/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015
1	lathosterolIBA 01/2015
1	immunoglobulin BIBA 07/2014
1	GlucosidasesIBA 06/2013
1	mosaprideIBA 01/2013
1	aliskiren FDA Link 08/2012
1	Antihypertensive Agents (Antihypertensives)IBA 08/2012
1	Ezetimibe (Zetia)FDA Link 05/2011
1	Sterol Regulatory Element Binding Protein 1IBA 05/2011
1	Bile Acids and Salts (Bile Acids)IBA 05/2011
1	Pyruvic Acid (Pyruvate)IBA 05/2011
1	Glutamic Acid (Glutamate)FDA Link 05/2011
1	Triglycerides (Triacylglycerol)IBA 05/2011
1	Transaminases (Aminotransferases)IBA 05/2011
1	LeptinIBA 04/2011
1	Dipeptidyl-Peptidase IV InhibitorsIBA 04/2011
1	Pravastatin (Pravachol)FDA LinkGeneric 10/2010
1	AdiponectinIBA 10/2010
1	InsulinsIBA 01/2010
1	Acarbose FDA LinkGeneric 01/2010
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2009
1	voglibose (Basen)IBA 02/2009
1	Biphasic InsulinsIBA 01/2009
1	MagnesiumIBA 07/2008
1	Codon (Codons)IBA 07/2008
1	thiazide receptorIBA 07/2008
1	trans-sodium crocetinate (crocetin)IBA 07/2008

Therapy/Procedure

4	Glycemic Control 08/2017 - 06/2013
4	Therapeutics 07/2014 - 01/2009
2	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 06/2018 - 03/2018
1	Nutrition Therapy (Medical Nutrition Therapy) 10/2013
1	Injections 01/2009